Cancer trial: retraining immune cells offers new hope for patients in personalized medicine breakthrough
Hand-out
Press Releases
Alloplex Biotherapeutics Inc.  
October 31, 2024

Cancer trial: retraining immune cells offers new hope for patients in personalized medicine breakthrough

BOSTON, Oct. 31, 2024 /PRNewswire/ -- In a remarkable development for cancer research, patients with advanced-stage cancer have benefited from SUPLEXA, a personalized treatment that trains the patient's own immune

avatar profile Olean Times Herald

Olean Times Herald


Local & Social